Xueli Li

1.9k citations
47 papers · 1.4k indexed · h-index 17
Topics
RNA modifications and cancer (7 papers)Cancer-related molecular mechanisms research (4 papers)Medical Image Segmentation Techniques (3 papers)
Journals
New England Journal of MedicineSHILAP Revista de lepidopterologíaScientific Reports
Partner nations
ChinaUnited StatesCanada

In The Last Decade

Xueli Li

43 papers receiving 1.4k citations

Peers

Xueli Li
Comparison fields: 5 of 110
  • Molecular Biology 875
  • Cancer Research 579
  • Pulmonary and Respiratory Medicine 274
  • Oncology 223
  • Surgery 99
Replace Ayla Ergün with:
Ayla Ergün United States
Gürkan Bebek United States
Yan Lin China
Kelsy C. Cotto United States
Adam Coffman United States
Susanna Kiwala United States
Xiaolei Shi China
Guoshuai Cai United States
Xueli Li relative to Ayla Ergün United States Ayla Ergün's profile →
Citations per field
00.5×2.7×
Ayla Ergün · 1×
Citations per year

Countries citing papers authored by Xueli Li

Since Specialization
Citations

This map shows the geographic impact of Xueli Li's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Xueli Li with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Xueli Li more than expected).

Fields of papers citing papers by Xueli Li

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Xueli Li. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Xueli Li. The network helps show where Xueli Li may publish in the future.

Co-authorship network of co-authors of Xueli Li

This figure shows the co-authorship network connecting the top 25 collaborators of Xueli Li. A scholar is included among the top collaborators of Xueli Li based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Xueli Li. Xueli Li is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
#WorkIndexed citations
1 0
2 2
3 5
4 8
5 7
6 2
7 4
8 34
9 24
10 14
11 8
12 5
13 328
14 14
15 14
16 14
17 19
18 31
19 386
20 2

About Xueli Li

Xueli Li is a scholar working on Dermatology, Cancer Research and Neurology, having authored 47 papers that have together received 1.4k indexed citations. Recurring topics across this work include RNA modifications and cancer (7 papers), Cancer-related molecular mechanisms research (4 papers) and Medical Image Segmentation Techniques (3 papers). The work is most often cited by research in Cancer Research (579 citations), Molecular Biology (875 citations) and Pulmonary and Respiratory Medicine (274 citations). Xueli Li has collaborated with scholars based in China, United States and Canada. Frequent co-authors include Eric B. Haura, Anupama Sharma, Tingan Chen, Gerold Bepler, Zhong Zheng, Andrew R. Hoffman, Lei Zhou, Jiuwei Cui, Ji‐Fan Hu and Naifei Chen. Their work appears in journals such as New England Journal of Medicine, SHILAP Revista de lepidopterología and Scientific Reports.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026